Emma Nicholson

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Annika Fendler, Scott T.C. Shepherd, Lewis Au et al. · Nature Cancer · 2021 · 185 citations · Full text

Life Sciences, Immunology, Oncology +13

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Dragana Milojković, Emma Nicholson, Jane F. Apperley et al. · Haematologica · 2009 · 123 citations · Full text

Medicine, Oncology, Pharmacology +14

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Anne M. Spanjaart, Per Ljungman, Rafael de la Cámara et al. · Leukemia · 2021 · 116 citations · Full text

Medicine, Hematology, Infectious Diseases +16

Envelope Glycoprotein Determinants of Increased Fusogenicity in a Pathogenic Simian-Human Immunodeficiency Virus (SHIV-KB9) Passaged In Vivo

Bijan Etemad-Moghadam, Ying Sun, Emma Nicholson et al. · Journal of Virology · 2000 · 100 citations

Life Sciences, Infectious Diseases, Molecular Biology +17